Advisors Preferred, LLC Pfizer Inc Transaction History

Advisors Preferred, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $45,908 - $53,115	1,271 Added 10.8%	13,044 $478,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $22,531 - $29,332	572 Added 5.11%	11,773 $480,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $467,641 - $610,454	11,201 New	11,201 $574,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $512,811 - $635,438	-11,209 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $61,318 - $90,895	1,484 Added 15.26%	11,209 $822,000
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $48,748 - $62,621	-1,242 Reduced 11.32%	9,725 $417,000
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $61,729 - $69,928	-1,719 Reduced 13.55%	10,967 $434,000
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $168,957 - $190,549	5,045 Added 66.03%	12,686 $461,000
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $93,147 - $118,444	-2,783 Reduced 26.7%	7,641 $281,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $100,965 - $118,455	3,180 Added 43.9%	10,424 $383,000
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $218,189 - $264,695	7,244 New	7,244 $244,000
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $989,608 - $1.12 Million	-30,061 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $976,681 - $1.27 Million	30,061 New	30,061 $1.08 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $293,025 - $321,936	-7,814 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $316,992 - $361,406	-8,240 Reduced 51.33%	7,814 $341,000
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $553,381 - $671,217	16,054 New	16,054 $708,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.